Cardiomyocyte Stiffness in Diastolic Heart Failure
2005 · Circulation · 530 citations
https://doi.org/10.1161/01.cir.0000155257.33485.6d
Z
Zoltán Papp
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
353
Papers
9.4K
Citations
46
h-index
149
i10-index
Zoltán Papp is an academic researcher from University of Debrecen. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Cardiomyopathy and Myosin Studies. The author has an h-index of 46, co-authored 301 publications.
ORCID: 0000-0002-4675-1542Papers by this author
worksEmpagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
2020 · Cardiovascular Research · 307 citations
https://doi.org/10.1093/cvr/cvaa123
Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients
2021 · International Journal of Infectious Diseases · 102 citations
https://doi.org/10.1016/j.ijid.2021.11.028
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
2020 · International Journal of Infectious Diseases · 78 citations
https://doi.org/10.1016/j.ijid.2020.11.184
Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans
2021 · Basic Research in Cardiology · 26 citations
https://doi.org/10.1007/s00395-021-00866-8
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
2019 · Journal of Translational Medicine · 22 citations
https://doi.org/10.1186/s12967-019-1978-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat